Published in J Infect Dis on April 01, 1989
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun (1992) 4.02
The physical map of the chromosome of a serogroup A strain of Neisseria meningitidis shows complex rearrangements relative to the chromosomes of the two mapped strains of the closely related species N. gonorrhoeae. J Bacteriol (1995) 3.10
Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci U S A (2001) 2.66
Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol (1991) 2.38
Molecular population genetic analysis of emerged bacterial pathogens: selected insights. Emerg Infect Dis (1996) 1.94
Characterization of Neisseria meningitidis isolated by ribosomal RNA gene restriction patterns and restriction endonuclease digestion of chromosomal DNA. Epidemiol Infect (1991) 1.89
Genetic population structure, clonal phylogeny, and pathogenicity of Salmonella paratyphi B. Infect Immun (1990) 1.68
Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens. Infect Immun (1996) 1.63
Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter. J Bacteriol (1995) 1.61
Sequence diversity, predicted two-dimensional protein structure, and epitope mapping of neisserial Opa proteins. J Bacteriol (1998) 1.53
Deletion of porA by recombination between clusters of repetitive extragenic palindromic sequences in Neisseria meningitidis. Infect Immun (1999) 1.51
Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden. J Clin Microbiol (1990) 1.45
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol Rev (1993) 1.26
Molecular epidemiology of serogroup a meningitis in Moscow, 1969 to 1997. Emerg Infect Dis (2001) 1.26
Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis. Infect Immun (1990) 1.12
Virulence evolution of the human pathogen Neisseria meningitidis by recombination in the core and accessory genome. PLoS One (2011) 1.12
Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease. Infect Immun (1994) 1.07
lpt6, a gene required for addition of phosphoethanolamine to inner-core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae. J Bacteriol (2004) 1.07
Sequencing of the porB gene: a step toward a true characterization of Neisseria meningitidis. Clin Vaccine Immunol (2006) 1.06
Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate. Clin Vaccine Immunol (2006) 1.04
Molecular epidemiology of recent belgian isolates of Neisseria meningitidis serogroup B. J Clin Microbiol (1998) 1.03
Identification of neisserial DNA binding components. Microbiology (2009) 1.01
Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide. Infect Immun (1990) 1.00
Characterization of serogroup A and B strains of Neisseria meningitidis with serotype 4 and 21 monoclonal antibodies and by multilocus enzyme electrophoresis. J Clin Microbiol (1991) 0.99
Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989. J Clin Microbiol (2006) 0.98
Surveillance and control of meningococcal meningitis epidemics in refugee populations. Bull World Health Organ (1990) 0.95
Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes. Infect Immun (1994) 0.89
Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis. J Clin Microbiol (1992) 0.88
Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies. Infect Immun (2006) 0.87
Two distinct outer membrane serotype subcomplexes of Neisseria meningitidis serogroup A. Infect Immun (1990) 0.86
Neisseria meningitidis Lacking the Major Porins PorA and PorB Is Viable and Modulates Apoptosis and the Oxidative Burst of Neutrophils. J Proteome Res (2016) 0.75
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A (1998) 39.20
Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature (2000) 9.86
Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature (2005) 9.50
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Averting a malaria disaster. Lancet (1999) 9.40
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71
Beginning a genetic analysis of conjugational transfer determined by the F factor in Escherichia coli by isolation and characterization of transfer-deficient mutants. J Bacteriol (1971) 8.45
Six widespread bacterial clones among Escherichia coli K1 isolates. Infect Immun (1983) 8.35
Free recombination within Helicobacter pylori. Proc Natl Acad Sci U S A (1998) 8.06
Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis (1985) 6.62
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32
The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis. Mol Biol Evol (1999) 6.23
Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. Lancet (1971) 6.05
Conjugation proteins encoded by the F sex factor. Nature (1977) 5.23
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc Natl Acad Sci U S A (2001) 4.80
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70
A versatile quick-prep of genomic DNA from gram-positive bacteria. Trends Genet (1995) 4.62
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis (1993) 4.02
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun (1992) 4.02
Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature (1992) 3.93
Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread. Mol Microbiol (1997) 3.79
A global gene pool in the neisseriae. Mol Microbiol (1996) 3.69
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64
Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis (1993) 3.63
Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg (1994) 3.58
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54
Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990. J Infect Dis (1994) 3.50
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40
Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health (1998) 3.38
Export without proteolytic processing of inner and outer membrane proteins encoded by F sex factor tra cistrons in Escherichia coli minicells. Proc Natl Acad Sci U S A (1979) 3.31
Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. Rev Infect Dis (1988) 3.28
Conjugational complementation analysis of transfer-deficient mutants of Flac in Escherichia coli. J Bacteriol (1972) 3.28
Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med (1977) 3.27
Autoimmune disease and parasitic infections in Nigerians. Lancet (1968) 3.22
Clonal analysis of descent and virulence among selected Escherichia coli. Annu Rev Microbiol (1986) 3.13
Mating aggregates in Escherichia coli conjugation. J Bacteriol (1975) 3.12
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
Immunosuppression in children with malaria. Lancet (1972) 3.11
Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun (1991) 3.11
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06
High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03
Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun (1994) 3.01
Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia. Bull World Health Organ (1997) 3.00
Allelic polymorphism and site-specific recombination in the opc locus of Neisseria meningitidis. Mol Microbiol (1996) 3.00
The control region of the F sex factor DNA transfer cistrons: restriction mapping and DNA cloning. Mol Gen Genet (1978) 2.95
Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet (2001) 2.89
Escherichia coli strains binding neuraminyl alpha 2-3 galactosides. Biochem Biophys Res Commun (1983) 2.87
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83
Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet (1974) 2.83
Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet (1986) 2.76
Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75
Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA. Microb Pathog (1988) 2.75
The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J (1994) 2.73
Carriage of pneumococci after pneumococcal vaccination. Lancet (1996) 2.69
Prevention and management of infections in patients without a spleen. Clin Microbiol Infect (2001) 2.67
Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci U S A (2001) 2.66
Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol (1994) 2.63
Placental malaria. I. Pathological classification. Histopathology (1993) 2.62
Allergic complications of meningococcal disease. II. Immunological investigations. Br Med J (1973) 2.61
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet (1991) 2.54
Cell--cell interactions in conjugating Escherichia coli: role of traT protein in surface exclusion. Proc Natl Acad Sci U S A (1977) 2.54
The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg (2001) 2.54
Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis. Mol Microbiol (2000) 2.52
The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol Microbiol (1994) 2.52
Assessment of clinical criteria for identification of severe acute lower respiratory tract infections in children. Lancet (1989) 2.51
Genetic analysis of transfer by the Escherichia coli sex factor F, using P1 transductional complementation. J Bacteriol (1972) 2.44
Deaths in infancy and early childhood in a well-vaccinated, rural, West African population. Ann Trop Paediatr (1987) 2.42
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Lipopolysaccharide, capsule, and fimbriae as virulence factors among O1, O7, O16, O18, or O75 and K1, K5, or K100 Escherichia coli. Infect Immun (1984) 2.42
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol (1989) 2.41
Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development. Microb Pathog (1987) 2.40
The limitations of verbal autopsy in a malaria-endemic region. Ann Trop Paediatr (1994) 2.40
Permethrin-treated bed nets (mosquito nets) prevent malaria in Gambian children. Trans R Soc Trop Med Hyg (1988) 2.40
Treponemal infection and the outcome of pregnancy in a rural area of The Gambia, west Africa. J Infect Dis (1992) 2.39
Impairment of the immune response to vaccination after acute malaria. Lancet (1978) 2.39
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect. Ann Rheum Dis (1997) 2.33
Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types. Infect Immun (1983) 2.33
Immunochemical characterization of Neisseria meningitidis serotype antigens by immunodiffusion and SDS-polyacrylamide gel electrophoresis immunoperoxidase techniques and the distribution of serotypes among cases and carriers. J Gen Microbiol (1980) 2.32
Assignment of tra cistrons to EcoRI fragments of F sex factor DNA. J Bacteriol (1978) 2.32
Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity. J Exp Med (1990) 2.29
Pallor as a clinical sign of severe anaemia in children: an investigation in the Gambia. Bull World Health Organ (1997) 2.28
Complement and meningococcal infection. Br Med J (1976) 2.28
Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals. Infect Immun (1986) 2.27
Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol Microbiol (1993) 2.26
Evidence for a malaria mitogen in human malaria. Nature (1975) 2.25
Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet (2000) 2.24
Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing. Infect Immun (1983) 2.24